According to Future Market Insights (FMI), the global Angiography Devices Market is estimated at USD 15.2 billion in 2026 and is forecast to reach USD 27.8 billion by 2036, expanding at a 6.2% CAGR during the forecast period. The market is being supported by recurring replacement demand, healthcare buyers standardizing device specifications, and hospitals adding imaging capacity. FMI identifies Magnetic Resonance Angiography (MRA) Devices as accounting for 20.0% of device revenue in 2026, while Coronary Angiography leads the procedure segment with 37.2%.

👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-1186

FMI reports that procurement teams are increasingly considering lifecycle economics, qualification requirements, supply continuity, and service coverage when selecting angiography equipment. The report identifies certification expenses and extensive requalification requirements as barriers to faster supplier substitution.

Global Segment Leaders

·         Magnetic Resonance Angiography (MRA) Devices — 20.0% share: MRA devices lead the device category because buyers value predictable performance, established familiarity, equipment availability, and lower requalification effort.

·         Coronary Angiography — 37.2% share: Coronary angiography leads the procedure category as specifications become increasingly standardized across hospital sites and cardiovascular imaging requirements sustain procurement.

·         Hospitals and Surgical Centers — 64.0% share: Hospitals and surgical centers account for the largest end-user share as replacement purchases and capacity additions concentrate incremental angiography volume among these facilities.

·         Cardiovascular Angiography — Leading application: FMI identifies cardiovascular angiography as the leading application in 2026, although the report page does not publish its percentage share.

·         Angiography Systems — Leading product: Angiography systems lead the product category in 2026, with no percentage share published on the accessible report page.

Country-Level Performance

·         China – 9.2% CAGR (2026–2036): Volume-based procurement (VBP) tenders and domestic device manufacturing under import-substitution policy.

·         India – 8.4% CAGR (2026–2036): Ayushman Bharat coverage expansion and private tertiary-care investment in metropolitan hospitals.

·         Germany – 6.5% CAGR (2026–2036): EU MDR re-certification cycles and statutory health insurance (GKV) reimbursement review.

·         USA – 6.1% CAGR (2026–2036): FDA clearance pathways and CMS reimbursement codes.

·         Brazil – 4.8% CAGR (2026–2036): SUS public procurement volumes and ANVISA registration requirements.

China is projected to be the fastest-growing profiled country at 9.2% CAGR, with FMI citing volume-based procurement tenders as the primary demand pull. Domestic device manufacturing under import-substitution policy provides an additional source of demand.

India follows at 8.4% CAGR. FMI identifies Ayushman Bharat coverage expansion as a structural driver, with specification activity concentrating in Maharashtra, Gujarat, and the National Capital Region where coverage expansion applies. Private tertiary-care investment in metropolitan hospitals also supports longer-term demand.

Germany is projected to grow at 6.5%, with procurement influenced by EU MDR re-certification cycles and statutory health insurance reimbursement review. The USA follows at 6.1%, where FDA clearance pathways and CMS reimbursement codes shape replacement and expansion decisions.

Brazil records the lowest CAGR among the profiled countries at 4.8%. FMI identifies SUS public procurement volumes as the primary demand factor, while ANVISA registration requirements influence the qualified buyer base for coronary angiography equipment.

👉 Access the Complete Report in PDF Format:
https://www.futuremarketinsights.com/reports/brochure/rep-gb-1186

Regional Context

Fast-growing markets — China and India: China and India are forecast to expand at 9.2% and 8.4%, respectively. China benefits from VBP tenders and domestic manufacturing, while India's growth is tied to healthcare-coverage expansion and private investment in tertiary-care hospitals.

Mature/slower-growth markets — Germany, USA and Brazil: Germany and the USA show more moderate growth as buyers place greater weight on regulatory qualification, reimbursement frameworks, documented performance, and supply continuity. Brazil's slower 4.8% CAGR reflects procurement patterns centered on public SUS volumes and ANVISA registration.

The full report covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa, with detailed forecasts across 30+ countries.

Market Drivers, Restraints and Opportunities

Recurring replacement demand is a key market driver. FMI reports that hospitals and surgical centers continue purchasing MRA devices as older installations are retired and imaging capacity is expanded. Buyers increasingly standardize specifications across sites to reduce switching costs and qualification requirements.

The coronary angiography segment accounts for 37.2% of procedure revenue, indicating the concentration of procurement around standardized cardiovascular imaging requirements. Suppliers able to provide configurations that integrate with existing workflows can potentially expand adoption without requiring complete workflow replacement.

Certification and requalification requirements remain a restraint. FMI notes that smaller buyers with limited engineering capacity can face greater difficulty when introducing new device specifications, slowing supplier substitution.

Service coverage and interoperability represent opportunities for suppliers. The report indicates that buyers evaluate qualification time and support response before committing to multi-site standardization, making lifecycle economics and dependable maintenance increasingly relevant to procurement decisions.

Competitive Landscape

The angiography devices market includes GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Boston Scientific, Medtronic, Terumo Corporation, Shimadzu Corporation, B. Braun Melsungen AG, and Abbott Laboratories. FMI identifies GE Healthcare and Siemens Healthineers as leading on scale, portfolio breadth, qualification depth, and global supply capability. Philips Healthcare maintains a global footprint, while Canon Medical Systems and Boston Scientific have more regionally concentrated positions.

GE Healthcare and Siemens Healthineers compete through supply depth and qualification support, while Philips Healthcare differentiates through portfolio breadth. Canon Medical Systems, Boston Scientific, Medtronic, Terumo, and Shimadzu compete through specialized configurations, pricing, and regional distribution. B. Braun focuses on underserved applications and regional markets.

The current FMI report page does not publish a dated “Key Developments” section, so no month/year company developments have been added to avoid introducing information not contained on the source page.

Analyst Perspective

Anurag Sharma, Principal Consultant at Future Market Insights, states:

“Hospital purchasing decisions increasingly extend beyond image quality toward workflow compatibility and lifecycle economics. Vendors offering interoperable systems with dependable maintenance coverage are able to protect long-term sourcing relationships across multisite healthcare networks. Competitive advantage is likely to favor platforms simplifying clinical operation and replacement planning without creating additional qualification burdens.”

Report Scope

The Angiography Devices Market report covers:

·         By Device: Magnetic Resonance Angiography (MRA) Devices, Computed Tomography Angiography (CTA) Devices, Conventional Angiography Devices, Digital Subtraction Angiography (DSA) Devices, Catheter Angiography Devices, Coronary Angiography Devices and Other Angiography Devices

·         By Procedure: Coronary Angiography, Pulmonary Angiography, Cerebral Angiography, Extremity Angiography and Renal Angiography

·         By End User: Hospitals and Surgical Centers, Diagnostic Centers, Academic and Research Institutes, and Ambulatory Surgical Centers

·         By Application: Cardiovascular Angiography, Neurovascular Angiography and Oncology Angiography

·         By Product: Angiography Systems, Catheters, Guidewires and Contrast Media Injectors

·         Regions: North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa

·         Countries specifically profiled: USA, China, India, Germany and Brazil

·         Historical Period: 2021–2025

·         Forecast Period: 2026–2036

·         2026 Market Size: USD 15.2 billion

·         2036 Forecast: USD 27.8 billion

·         CAGR: 6.2%

Access Full Report: https://www.futuremarketinsights.com/reports/angiography-devices-market

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market research and consulting services, offering syndicated and customized research across industries including healthcare, medical devices, and pharmaceuticals.

Related Reports:

·         https://www.openpr.com/news/4650091/cold-plasma-market-to-reach-usd-10-39-billion-by-2035-at-13-9

·         https://www.openpr.com/news/4650094/angiography-devices-market-to-reach-usd-27-8-billion-by-2036

·         https://www.openpr.com/news/4650097/pen-needles-market-to-reach-usd-13-3-billion-by-2035-at-11-7-cagr

·         https://www.openpr.com/news/4650100/lip-injection-market-to-reach-usd-7-4-billion-by-2035-at-7-3-cagr

·         https://www.openpr.com/news/4650103/sepsis-diagnostics-market-to-reach-usd-1-5-billion-by-2036-at-7-9

About Future Market Insights (FMI)

Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries. The firm delivers detailed forecasts, technology analysis, and data-driven recommendations that support informed decision-making for manufacturers, investors, distributors, and policymakers worldwide.

For Press & Corporate Inquiries

Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075

For Sales – sales@futuremarketinsights.com
For Media – Rahul.singh@futuremarketinsights.com
For Web – https://www.futuremarketinsights.com